Suchergebnis | Hamburg Open Science

Facetten

30 Einträge gefunden

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
2009 - Forschungsinformationssystem des UKE
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
2008 - Forschungsinformationssystem des UKE
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
2008 - Forschungsinformationssystem des UKE
Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
2008 - Forschungsinformationssystem des UKE
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
2007 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Management of erectile dysfunction after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Ejaculatory disorders may affect screening for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
2007 - Forschungsinformationssystem des UKE
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.

Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.

Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Management of erectile dysfunction after radical prostatectomy in 2007.

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

Ejaculatory disorders may affect screening for prostate cancer.

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.

External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.